AstraZeneca, Oxford vaccine study allowed to restart in UK

The U.K. drugs regulator and an independent committee have agreed to let vaccinations with AstraZeneca and the University of Oxford's experimental coronavirus shot resume at U.K.-based clinical trial sites, less than a week after testing was paused for a safety review.